Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label, single-arm, multicenter brivaracetam pharmacokinetics in pediatric epilepsy
2006-006536-22Phase 2Completed
- Sponsor
- UCB
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of brivaracetam in epilepsy, Focal Onset Epilepsy and epilepsy syndrome, sponsored by UCB. Primary endpoints: Plasma concentrations of brivaracetam and metabolites and Plasma concentrations of concomitant antiepileptic drugs. Started May 2011; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset Epilepsyepilepsy syndrome
Beyond the preview
Go deeper on 2006-006536-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006536-22.